Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$87,367,946
-$10,503,433 QoQ
Shares Held
3,628,237
+4.1% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#109
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $1,882,423,234 across 16 Drug Manufacturers - General names. PFE ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,817,391 | $457,328,271 | |
| 2 | LLY |
ELI LILLY & Co
|
308,951 | $370,565,128 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,054,383 | $263,988,215 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,763,525 | $222,803,748 | |
| 5 | JNJ |
Johnson & Johnson
|
783,288 | $198,931,653 | |
| 6 | AMGN |
Amgen Inc
|
516,543 | $187,050,551 | |
| 7 | PFE |
Pfizer Inc
This page
|
3,628,237 | $87,367,946 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
607,026 | $34,976,838 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,367,946 | 3,628,237 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $97,871,379 | 3,485,448 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,624,042 | 3,278,074 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $107,967,601 | 4,237,347 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $103,612,328 | 4,274,436 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $157,534,244 | 6,216,821 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,503,312 | 1,413,619 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $40,877,952 | 1,412,507 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $40,514,032 | 1,447,964 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $41,888,181 | 1,509,484 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $56,498,388 | 1,962,431 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $89,483,505 | 2,697,724 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $92,600,530 | 2,524,551 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $64,429,524 | 1,579,155 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $78,589,401 | 1,533,751 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $63,702,613 | 1,455,727 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $68,177,560 | 1,300,354 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $61,601,951 | 1,189,916 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $60,130,260 | 1,018,294 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $39,246,538 | 912,498 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $30,317,985 | 774,208 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $27,653,344 | 763,272 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $24,907,854 | 676,660 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $23,441,367 | 638,730 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $22,458,710 | 686,810 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $20,946,822 | 641,754 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||